On the other hand, low lactose
content at the free cells treatment was observed in
comparison with the other treatments, which could be
due to the behaviour of B. bifidum F-35 in metabolising
lactose and producing lactic and acetic acids as
was implied by Kaminarides et al.(2007) and Bano
et al.(2011).